Recent Finacing
Recent Raise
ObsEva is a Geneva-based biopharma developing oral therapeutics for reproductive medicine, advancing candidates for endometriosis, uterine fibroids, preterm labor and IVF embryo-transfer (nolasiban, linzagolix, OBE001).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
